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ClC-3 is an intracellular chloride transport protein known to reside on endosomes and synaptic vesicles. The endogenous protein has
been notoriously difficult to detect in immunohistological experiments because of the lack of reliable antibodies. Using newly generated
antibodies,wenowexamine its expressionpattern at the cellular and subcellular level. In all tissues examined, immunostaining indicated
that ClC-3 is a vesicular protein, with a prominent expression in endocrine cells like adrenal chromaffin cells and pancreatic islet cells. In
linewith apossible functionofClC-3 in regulating vesicle traffickingor exocytosis in those secretory cells, capacitancemeasurements and
amperometry indicated that exocytosis of large dense-core vesicles (LDCVs) was decreased in chromaffin cells from ClC-3 knock-out
mice. However, immunohistochemistry complemented with subcellular fractionation showed that ClC-3 is not detectable on LDCVs of
endocrine cells, but localizes to endosomes and synaptic-like microvesicles in both adrenal chromaffin and pancreatic  cells. This
observation points to an indirect influence of ClC-3 on LDCV exocytosis in chromaffin cells, possibly by affecting an intracellular
trafficking step.
Key words: Clcn3; gene disruption; catecholamine; insulin; channel; exchanger
Introduction
ClC-3 is a member of the CLC gene family encoding Cl chan-
nels and Cl/H exchangers (Jentsch, 2008). Of the nine mam-
malian CLC proteins, four members are plasma membrane Cl
channels, whereas the others, including ClC-3, reside predomi-
nantly in intracellular membranes (Jentsch, 2007). ClC-4 and
ClC-5, previously classified as Cl channels (Friedrich et al.,
1999), are now known to be Cl/H exchangers (Picollo and
Pusch, 2005; Scheel et al., 2005; Zdebik et al., 2008), like the
bacterial ecClC-1 (Accardi and Miller, 2004). The high degree of
sequence identity of ClC-3 to ClC-4 and ClC-5 and their almost
identical current properties (Friedrich et al., 1999; Li et al., 2002;
Picollo and Pusch, 2005; Matsuda et al., 2008) strongly suggest
that ClC-3 is an antiporter also (Jentsch, 2007, 2008).
Intracellular CLC proteins are thought to facilitate endoso-
mal/lysosomal acidification by shunting currents of proton
pumps (Jentsch, 2007). The disruption of vesicular CLCs has
diverse effects including impaired renal endocytosis and kidney
stones with a loss of ClC-5 (Lloyd et al., 1996; Piwon et al., 2000;
Wang et al., 2000), lysosomal storage disease with a loss of ClC-6
(Poe¨t et al., 2006), and osteopetrosis associated with lysosomal
storage disease with a loss of either ClC-7 (Kornak et al., 2001;
Kasper et al., 2005) or its -subunit Ostm1 (Lange et al., 2006).
Disruption of ClC-3, which is located on endosomes and syn-
aptic vesicles (SVs), leads to a severe neurodegeneration resulting
in an absence of the hippocampus (Stobrawa et al., 2001). This
neurodegeneration is not associated with the massive intraneu-
ronal deposits of lysosomal storage material found in mice lack-
ing ClC-6 (Poe¨t et al., 2006), ClC-7 (Kasper et al., 2005), or
Ostm1 (Lange et al., 2006). Although CNS degeneration is the
salient feature of ClC-3 knock-out (KO) mice (Stobrawa et al.,
2001; Dickerson et al., 2002; Yoshikawa et al., 2002), ClC-3 is
expressed in many other tissues (Kawasaki et al., 1994; Borsani et
al., 1995; Stobrawa et al., 2001).Unfortunately, the lack of reliable
antibodies has hampered a thorough expression analysis.
Several incompatible functions were ascribed to ClC-3. It was
suggested to mediate swelling-activated Cl currents (Duan et
al., 1997) or (different) Ca2-activated Cl currents (Huang et
al., 2001; Wang et al., 2006) in plasma membranes. Clcn3/
mice lacked neither current (Stobrawa et al., 2001; Arreola et al.,
2002; Gong et al., 2004). ClC-3 was also proposed to have roles in
neutrophil and smooth muscle reactive oxygen species genera-
tion (Moreland et al., 2006; Miller et al., 2007) and in  cell
insulin secretion (Barg et al., 2001).
We have generated new ClC-3 antibodies to investigate its
subcellular distribution in a range of tissues in a KO-controlled
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manner and find that ClC-3 is highly expressed in neurosecretory
cells of the adrenal medulla, endocrine pancreas and pituitary. In
both chromaffin cells and pancreatic  cells, ClC-3 was found on
endosomes and synaptic-like microvesicles (SLMVs), but could
not be detected on large dense-core vesicles (LDCVs). Surpris-
ingly, chromaffin cell secretion was impaired in Clcn3/ mice.
These results suggest that ClC-3 influences LDCV exocytosis of
chromaffin cells indirectly.
Materials andMethods
Mice. The generation of the ClC-3 KO mice has been described previ-
ously (Stobrawa et al., 2001). For the present study, animals of a mixed
SVJ129–C57BL/6 background were used because they exhibit a reduced
lethality compared with a C57BL/6 backcrossed strain. Littermates were
taken as controls.
Antibodies. New antibodies were generated against six different
epitopes of themouse ClC-3 protein, but only sera 1035 and 1036 against
a mixture of two peptides (C3/03A, SSTHLLDLLDEPIPGC; C3/03B,
KDRERHRRINSKKKEC), which represent parts of the ClC-3 cytoplas-
mic N terminus, proved useful. Their specificity was confirmed by com-
paring Western blots of wild-type (WT) and ClC-3 KO tissue (supple-
mental Fig. S1A, available at www.jneurosci.org as supplemental
material). Affinity purification was performed against peptide A or pep-
tide B independently. Only sera affinity-purifiedwith peptide A (which is
present in ClC-3 from mice, men, and cattle) gave strong signals in
Western blots and recognized ClC-3 in immunohistochemistry. These
antibodies proved superior in immunohistochemistry to the 3A4 anti-
body that we had generated against a different N-terminal ClC-3 epitope
(Stobrawa et al., 2001), and which we used in Western blot experiments
(supplemental Figs. S1, S3, available at www.jneurosci.org as supplemen-
tal material). The successful peptide C3/03A differs in 6 and 10 of 15 aa
from the corresponding sequences of the related ClC-5 and ClC-4 pro-
teins, respectively. Accordingly, the antibody did not show noticeable
cross-reactivity to either protein.
Other antibodies used in this study are rabbit anti-ClC-3 3E3 gener-
ated against a C-terminal peptide (Stobrawa et al., 2001), rabbit anti-
ClC-4 12.61 (directed against an epitope between the CBS domains; T. J.
Jentsch and S. Schaffer, unpublished data), rabbit anti-ClC-5 5A1 and
5E1 (Gu¨nther et al., 1998), rabbit anti-ClC-6 6N2 (Poe¨t et al., 2006),
rabbit anti-ClC-7 7N4B (Kornak et al., 2001; Kasper et al., 2005), mouse
anti-villin (Acris), mouse anti-synaptophysin SVP-38 (Sigma), guinea
pig anti-insulin (Euro-Diagnostika), mouse anti-glucagon (Sigma), rab-
bit anti-somatostatin (Progen), rabbit anti-pancreatic polypeptide (Pro-
gen), rabbit anti-secretogranin I and II (kind gift fromW.Huttner,Max-
Planck-Institut fu¨r Molekulare Zellbiologie und Genetik, Dresden,
Germany), rabbit anti-actin (Sigma), rabbit anti-cathepsin D (Onco-
gene), mouse anti-carboxypeptidase E (Research Diagnostics), rabbit
anti-rab4 (Santa Cruz Biotechnology), mouse anti-transferrin receptor
(Zymed), rat anti-HA 3F10 (Roche), and mouse anti-myc 9E10 (Santa
Cruz Biotechnology). All mouse and rat antibodies were monoclonal.
Immunohistochemistry on sections. Mice were perfused transcardially
with 4% paraformaldehyde (PFA) in PBS for 5 min. Paraffin sections
were cooked in citrate buffer for antigen retrieval and blocked in 3%
NGS, 2% BSA, and 0.1% Triton X-100 in PBS. The first antibody was
applied in 2% BSA, 0.1% Triton X-100 in PBS, and the second antibody
in 0.1% Triton X-100 in PBS. Antibody dilutions were 1:100 (villin),
1:200 (ClC-5 5E1, synaptophysin), 1:300 (ClC-3 1036), 1:400 (pancreatic
polypeptide), 1:500 (ClC-7), 1:800 (somatostatin), 1:2000 (insulin, glu-
cagon, secretogranin II), and 1:1500 for the Alexa-conjugated secondary
antibodies (Invitrogen). Nuclei were stained with TO-PRO-3 (Invitro-
gen). Sections were examined by confocal microscopy (Leica TCS).
Isolation of chromaffin cells and pancreatic islets. Chromaffin cells were
isolated from adrenal glands of 6- to 8-week-old mice. The adrenal me-
dulla was dissected in cold Locke’s buffer (in mM: 154 NaCl, 5.6 KCl, 3.6
NaHCO3, 5.6 glucose, and 5.0 HEPES, pH 7.4) and incubated with 3
mg/ml collagenase type A (Roche) in Locke’s buffer in a shaking bath at
37°C. The collagenase was diluted further in cold Locke’s buffer, and cells
were pelleted and resuspended in DMEM supplemented with 1% peni-
cillin/streptomycin (Invitrogen) and 10% FCS (JRH Biosciences) and
then filtered through nylonmesh. Cells were pelleted again, resuspended
in supplemented DMEM, plated on poly-L-lysine coated glass coverslips,
and incubated at 37°C with 5% CO2. Cells were maintained in primary
culture for 2–4 d before experiments.
To prepare pancreatic islets, adult mice were killed by cervical dislo-
cation, the pancreas was injected with collagenase solution [0.67 U col-
lagenase P (Roche)/ml Hanks’ solution), excised and incubated at 37°C
for 17 min. Incubation was stopped by adding cold Hanks’ solution
containing 1 mg/ml BSA. Islets were dissociated from the exocrine tissue
by vigorous shaking and were picked from the suspension under visual
control of a binocular. To dissociate islets into single cells, they were
incubatedwithCa2-free solution (inmM: 138NaCl, 5.6KCl, 1.2MgCl2,
5 HEPES, 3 glucose, 1 EGTA, and 0.1% BSA, pH 7.4) for 10 min at 37°C.
The islets were then triturated by pipetting.
Expression and detection of ClC-3 in INS-1E cells and chromaffin cells.
To express ClC-3 in insulinoma (INS-1E) cells and chromaffin cells, the
Semliki Forest virus (SFV) system was used (Owe-Larsson et al., 1999).
ClC-3 containing a C-terminal hemagglutinin (HA) or myc epitope was
cloned into pSFV1 (Invitrogen). INS-1E cells or primary chromaffin cells
(24 h after preparation) were incubated for 12–24 h with activated re-
combinant virus. Cells were fixed in 4% PFA in PBS and blocked in 5%
normal donkey serum, 0.1%Triton X-100 in PBS. The first antibody was
applied in 0.1% Triton X-100 in PBS overnight at 4°C. Antibody dilu-
tionswere 1:500 (HA), 1:2000 (insulin, secretogranin II), and 1:20 (myc).
After washing, cells were incubated with Alexa-conjugated secondary
antibodies (Invitrogen). Samples were examined by confocalmicroscopy
(Leica TCS).
Generation of cell and tissue lysates for Western blotting. Dissected tis-
sues or pelleted cells were homogenized in PBS containing 1%NP-40 and
protease inhibitors. After 30min on ice, homogenates were centrifuged 5
min at 14,000 rpm at 4°C. Supernatants were complemented with load-
ing buffer and 4% -mercaptoethanol, heated to 55°C for 5 min and
subjected to SDS-PAGE and Western blotting.
Subcellular fractionation of  cells. INS-1E or Rinm5F cells from three
140 mm cell culture dishes were scraped into PBS; primary islet cells
(which are 80%  cells) were isolated from 12 adult WT animals and
pooled. Cells were pelleted by centrifugation, resuspended in 1.5 ml of
homogenization buffer [5 mM HEPES, 0.5 mM EGTA, 1 Complete
protease inhibitor (Roche), pH 7.4] and homogenized by nitrogen cavi-
tation (150 psi, 30 min, 4°C). The homogenate was centrifuged (10 min,
3000 g, 4°C), and the supernatant was loaded onto the top of a contin-
uous sucrose density gradient (0.45–2 M sucrose in homogenization
buffer). After centrifugation (30,000 rpm, 18 h, 4°C) in an SW41 rotor
(Beckman), 750 l fractions were collected from the top of the gradient.
The sucrose content of each fraction was determined by measuring its
refractive index. Protein content was analyzed using the BCA protein
assay kit (Pierce). Insulin contentwas determined using anUltrasensitive
Mouse Insulin ELISA (Crystal Chem). -Hexosaminidase activity was
measured by incubating 10 l of the fractions with 100 l of substrate
solution (10 mM para-nitrophenyl-2-acetamido-2-deoxy--D-gluco-
pyranoside, 0.1 M sodium citrate, pH 4.6, 0.2%BSA) for 2 h at 37°C. After
addition of 1 ml of 0.2 M glycine, pH 10.8, samples were measured in a
photometer at 405 nm. For Western blot analysis of the fractions, anti-
bodies against ClC-3 (3A4, 3E3, 1:500), ClC-5 (5A1, 1:500), ClC-6 (1:
500), ClC-7 (1:500), carboxypeptidase E (1:500), synaptophysin (1:500),
transferrin receptor (1:500), rab4 (1:200), and cathepsinD (1:40)were used.
Glycerol velocity gradients. Glycerol velocity gradients were performed
as described (Cameron et al., 1991). Briefly, INS-1E cell supernatants
were prepared as described above for sucrose gradients [except that the
homogenization buffer was (in mM) 150 NaCl, 10 HEPES, 1 EGTA, 0.1
MgCl2, and 1 Complete protease inhibitor (Roche), pH 7.4] and
loaded onto a 5–25% continuous glycerol gradient with a 50% sucrose
cushion. After centrifugation (48,000 rpm, 1 h, 4°C) in a SW40 rotor
(Beckman), 1ml fractionswere collected from the top of the gradient and
analyzed by Western blotting as described for sucrose gradients.
Subcellular fractionation of adrenal medullary tissue. Medullary tissue
was dissected from fresh bovine adrenal glands andhomogenized in 0.3M
sucrose in 10mMTris, pH 7.4. The homogenate was centrifuged twice for
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10min at 800 g. The resulting supernatant was centrifuged at 20,000
g for 20 min. The pellet was resuspended in the homogenization buffer
and loaded onto a 16-step gradient. Sixteen times 2 ml of 1.9 to 0.4 M
sucrose in 0.1 M sucrose steps was layered onto 3.5ml of 2 M sucrose in 10
mM Tris, pH 7.4. After 16 h at 100,000 g at 4°C in an SW28 rotor, 20 2 ml
fractions were taken from top to bottom. An aliquot of each fraction was
used to determine -hexosaminidase activity. The remainder was sub-
jected to TCA precipitation. Equal amounts of protein per fraction were
separated by SDS-PAGE and analyzed by Western blotting.
Capacitance measurements with depolarization protocol. Recordings
were made in the whole-cell patch-clamp configuration. Electrodes had
input resistances of 3–5M. Recordings were performed with an EPC-9
amplifier (HEKA) and Pulse software (version 8.53; HEKA). For capac-
itance recordings, the pipette solution contained (in mM) 50 CsCl, 75
Cs2SO4, 10NaCl, 3MgSO4, and 10HEPES, pH 7.3. The external solution
for these recordings consisted of (in mM) 20 tetraethylammonium
(TEA)-Cl, 118 NaCl, 5 KCl, 5 CaCl2, 0.5MgCl2, 5 HEPES, and 3 glucose,
pH 7.4. Whole-cell capacitance and series resistance were compensated
before experiments. Exocytosis was monitored as changes in cell capaci-
tance, using the sine plus DC mode of the lock-in amplifier (40 mV
peak-to-peak amplitude wave at 1 kHz) included in the Pulse software
suite (Pulse Software). Secretion was elicited by trains of ten 500 ms
depolarizations (1 Hz stimulation frequency) from70–0 mV. During
all patch-clamp experiments, cells were continuously superfusedwith the
extracellular medium at a rate of 2 ml/min. All measurements were
performed at 32–35°C.
Capacitance measurements with caged calcium release.Outputs of a UV
flash lamp (Rapp OptoElektronik) and of a monochromator (Poly-
chrome IV; TILL Photonics) were coupled into the epifluorescence port
of an inverted Axiovert 200 microscope equipped with a 100 Fluar
objective (Zeiss). Cells were patched at room temperature in the whole-
cell mode, and their interior was equilibrated with the pipette solution
containing (in mM) 110 cesium glutamate, 8 NaCl, 2 MgATP, 0.3 Na2-
GTP, 20 HEPES, 5 nitrophenyl-EGTA, 3.5 CaCl2, 0.3 furaptra, and 0.2
fura-2, adjusted to pH 7.2 with CsOH (300–310 mOsm). The external
bathing solution contained (in mM) 20 TEA-Cl, 118 NaCl, 5 KCl, 5
CaCl2, 0.5 MgCl2, 5 HEPES, and 3 glucose, pH 7.4 (310–320 mOsm).
Ca2 was released from Ca2-bound nitrophenyl-EGTA by a flash of
300 V. As control, [Ca2]i was measured by intermittently exciting
fura-2 and furaptra (Invitrogen) at 350 and 380 nm (Xu et al., 1997;
Voets, 2000). Cellular fluorescence at 510 nm was measured using a
photodiode. The [Ca2]i liberated from Ca
2-bound nitrophenyl-
EGTA by UV flash ranged between 5 and 20 M and did not differ
between WT and KO cells. The mean of the recorded capacitance values
before UV flash was subtracted from the capacitance recorded at each
time point to determine the capacitance increaseC. TheC values were
averaged over time and represented as mean SEM. All measurements
were performed at 32–35°C.
Amperometry.Catecholamine release from single chromaffin cells was
measured using amperometry (Chow et al., 1992). A carbon-fiber elec-
trode (ProCFE; Dagan) was placed on a chromaffin cell and 800 mV
was applied to the electrode under voltage-clamp conditions. Current
caused by catecholamine oxidation was recorded using an Axopatch
200A amplifier and pClamp 8.0 software (Molecular Devices), sampled
at 10 kHz and low-pass filtered at 1 kHz. For quantitative analysis, secre-
tory spikes were analyzed (Mini Analysis, version 6.0.1; Synaptosoft) for
a period of 60 s from the start of stimulation. The standard bath Krebs
solution contained (in mM) 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 5
D-glucose, and 10HEPES, pH 7.4. High-K-containing solution was the
same as control bath solution except that 50mMK replaced an equimo-
lar amount of NaCl. All solutions were applied to cells using a gravity
perfusion system, the outlet of which was placed within 500m from the
recorded cell. All experiments were performed at 32–35°C. For foot anal-
ysis, data were pooled from all recorded cells because many recordings
contained a low number of foot signals so that an adequate median value
could not be obtained for each cell. Foot onset was defined when the
signal exceeded the peak-to-peak noise of a 5 ms time segment, whereas
the end of the foot was defined by the inflection point between the foot
and the main event. This threshold value was determined by taking the
second derivative of the trace. Recordings of bothWT and KO cells used
the same carbon fibers to eliminate potential effects of interfiber variabil-
ity. Foot signals were analyzed only when they had amplitudes four times
greater than the root mean squared noise value of the baseline and which
lasted for longer than 1 ms.
Ca2measurements.Chromaffin cells were loaded with the Ca2 sen-
sitive dye fura-2 AM (15M) and 0.02% Pluronic F-127 (Invitrogen) for
30 min at 37°C in serum-free DMEM and then washed in Krebs solution
for 15 min. Fura-2 excitation was excited using a multiple wavelength
monochromator (Polychrome IV; TILL Photonics). The emitted light
was bandpass filtered at a wavelength of 510 nm. Images were obtained
using a 40water-immersion objective fitted to a CCD camera (Imago)
on an upright microscope (Olympus BXWI50) and stored for later anal-
ysis using TILLvisION software (version 4.0; TILL Photonics). Fluores-
cence intensities from individual cells were measured at a rate of 1 Hz.
[Ca2]i was expressed as the ratio of fura-2 fluorescence intensity at 340
nmdivided by that at 380 nm. The [Ca2]i during the control periodwas
subtracted from the [Ca2]i during the peak response to stimulation to
give 340/380.
Hormone measurements. Serum and islet insulin levels were measured
with an Ultrasensitive Mouse Insulin ELISA Kit (Crystal Chem). Serum
leptin levels were determined using a mouse leptin ELISA Kit (Crystal
Chem). Epinephrine and norepinephrine in mouse serum and urine
were detected using a Cat Combit ELISA Kit (IBL). Adrenal gland cate-
cholamine content was determined using a direct fluorometric assay as
described by Lelkes et al. (1985).
Data analysis. Data are reported as mean values  SEM of the indi-
cated number of experiments. Statistical significance was evaluated using
Student’s t test.
Results
ClC-3 is expressed in vesicular structures in various tissues
We generated antibodies in rabbits against a mixture of two pep-
tides representing amino acids 9–23 (peptide A) and 50–64
(peptide B) of the cytoplasmic N terminus of mouse ClC-3. After
affinity purification against peptide B, the serum recognized a
major broad band of the correct size in Western blots of mem-
branes from WT, but not ClC-3 KO kidneys (supplemental Fig.
S1A, available at www.jneurosci.org as supplemental material).
The rather broad width of this band is typical and has been as-
cribed to the glycosylation of ClC-3 (Schmieder et al., 2001). The
absence of a band in ClC-3 KO kidney samples suggests that
cross-reactivity to ClC-5, which is prominently expressed in kid-
ney (Gu¨nther et al., 1998), is negligible.
This new antibody was used in immunocytochemistry to in-
vestigate the expression of ClC-3 in various tissues, always using
sections from ClC-3 KO mice (Stobrawa et al., 2001), to control
for the specificity of staining (supplemental Fig. S1B–G, available
at www.jneurosci.org as supplemental material). In the kidney,
KO-controlled staining was observed intracellularly in the apical
part of proximal tubular cells (Fig. 1A–D). Costaining with the
brush border protein villin revealed that ClC-3 expression was
not detected in the plasma membrane, but in an intracellular
region apposed to it (Fig. 1B). In epithelia of the epididymis, an
intracellular vesicular staining was observed as well (Fig. 1E,F).
Similar to the staining of proximal tubules, it was most intense at
the apical cell pole. In hepatocytes, we observed an intracellular,
granular staining that was often concentrated close to nuclei (Fig.
1G,H).
In the brain (Fig. 1 I–O), ClC-3 staining was broadly observed
in neuronal cell bodies and neuropil. Because the presence of
ClC-3 is crucial for the maintenance of an intact hippocampus,
we analyzed its subcellular expression pattern especially in the
hippocampal region. In the CA3 region (Fig. 1 I), the neuropil of
the stratum oriens was stained as heavily as the neuronal cell
bodies. The hilus of the dentate gyrus, which containsmossy fiber
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terminals, was also strongly stained (Fig. 1K). The vesicular stain-
ing of neuronal cell bodies is compatible with the known local-
ization of ClC-3 to endosomes, whereas the staining of the neu-
ropil conforms to its presence on synaptic vesicles. Indeed, ClC-3
partially colocalizes with the synaptic vesiclemarker synaptophy-
sin and shows robust staining of the surrounding neuropil, as
demonstrated for the CA3 region of the hippocampus in Figure
1M–O. In the retina, which degenerates early in ClC-3 KO mice,
ClC-3wasmainly detected in the synapse-rich inner and outer plex-
iform layers (supplemental Fig. S2A, available at www.jneurosci.org
as supplemental material), in accord with our previous results
with a different antibody (Stobrawa et al., 2001).
Because ClC-3 had been suggested to have a role in exocytosis
(Barg et al., 2001), we investigated the expression of ClC-3 in
various secretory cell types (Fig. 2). All areas of the neuronal
posterior lobe of the pituitary stained for ClC-3 in an intense
dot-like staining pattern (Fig. 2A). In the anterior lobe of the
pituitary, only a small subset of cells showed prominent intracel-
lular staining (Fig. 2B). Likewise, there was only a subpopulation
of cells stained in the thyroid gland (Fig. 2C,D). Adrenal glands
Figure 1. Intracellular vesicular staining for ClC-3 in diverse organs. In the kidney, ClC-3 is prominently expressed in the apical region of proximal tubular (PT) cells as indicated by green staining.
A–D, Counterstaining for the brush-border protein villin (red;B,D) shows that ClC-3 resides in vesicles below the plasmamembrane. These structureswere not stained in PT cells fromClC-3 KOmice
(C, D) demonstrating the specificity of the ClC-3 antibody. E, F, ClC-3 staining of apical vesicles is also seen in epididymal epithelial cells of 2-week-old WTmice (E), but not in KOmice (F ). G, H, In
liver, granular staining for ClC-3 appears close to nuclei (G) and is absent in KO controls (H ). I,K, In brain, there is strong expression of ClC-3 in cell bodies (b) and neurites (n) of the CA3 region of the
hippocampus (I ) and of the dentate gyrus (K ). J, L, Staining is absent in the respective KO controls.M–O, ClC-3 and synaptophysin partially colocalize in the neuropil surrounding the CA3 neurons.
TO-PRO-3 was used in O to stain nuclei. Scale bars: A–D,M–O, 10m; E, F, 15m; G, H, 7.5m; I–L, 25m.
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showed intense, KO-controlled staining for ClC-3within theme-
dulla (Fig. 2E). Staining of the cortex was less intense and was
predominantly observed in the aldosterone-producing zona glo-
merulosa (Fig. 2F). Endocrine pancreatic islets of Langerhans
were intensely stained in a fine vesicular pattern that covered the
entire cytoplasm (Fig. 2G). In exocrine epithelial cells of the pan-
creas, the ClC-3 antibody again stained vesicular structures
(Fig. 2H).
Distinct cell types within islets secrete different hormones.
Insulin-secreting  cells constitute the bulk of islet cells (60–
80%), with glucagon-secreting  cells being the second largest
cell population (20%). The remaining somatostatin-producing
 cells as well as the pancreatic polypeptide secreting PP cells
constitute5% each. ClC-3 is expressed in all secretory cell types
of pancreatic islets (supplemental Fig. S2B, available at www.
jneurosci.org as supplemental material). No difference in the
staining intensity between these different neuroendocrine cells
was noted.
Capacitance measurements indicate reduced exocytosis of
ClC-3 KO chromaffin cells
The prominent expression of ClC-3 in several secretory cell types
prompted us to investigate whether the disruption of ClC-3 (Sto-
brawa et al., 2001) might influence their secretory capacity. We
chose isolated chromaffin cells as an easily amenable and well
established model system for exocytosis (Borges et al., 2008),
which we monitored by capacitance measurements. Using volt-
age clamp in the standard whole-cell configuration, exocytosis
was elicited by trains of ten 500 ms pulses that depolarized the
cells from 70 to 0 mV (Fig. 3A). In WT chromaffin cells, exo-
cytosis proceeded throughout the train. The capacitance increase
per pulse decreased from 214  32 fF in response to the first
depolarization to a final value of 53 13 fF/pulse. Such a decrease
is expected because the limited pool of readily releasable granules
is rapidly depleted during repetitive stimulation and is more
slowly refilled. The total capacitance increase of WT cells aver-
aged 1030 78 fF. In chromaffin cells lacking ClC-3, exocytosis
also proceeded throughout the pulse train but capacitance in-
creases per pulse weremarkedly lower (Fig. 3A,B). The first pulse
increased capacitance on average by 136 25 fF ( p 0.05 com-
pared with WT). The total increase after 10 pulses amounted to
566 77 fF ( p 0.05 comparedwithWT), nearly one-half of the
amount observed inWT cells (Fig. 3B). The initial surface area of
the cells was comparable. The decreased response to the first
pulse suggests that the blunted exocytosis of ClC-3 KO cells can-
not be ascribed exclusively to an impairment of the refilling of the
readily releasable pool, but indicates a reduction of this pool
itself. Depolarization-induced exocytosis involves increases of in-
tracellular Ca2 that result from the opening of voltage-gated
Ca2 channels. To measure Ca2-induced exocytosis directly,
we strongly raised [Ca2]i by flash photolysis of caged Ca
2,
whichwas introduced into the cell through the patch pipette (Fig.
3C,D). In WT chromaffin cells, this procedure led to an average
capacitance increase of 389 114 fF compared with 101 42 fF
in KO cells ( p 0.05),25% of this value (Fig. 3D).
Amperometry reveals details of LDCV exocytosis in ClC-3 KO
chromaffin cells
The exocytosis of catecholamine-containing vesicles can also be
monitored by amperometry (Chow et al., 1992). The oxidative
current that is flowing through a nearby carbon-fiber microelec-
trode reflects the secreted LDCV content, but also depends on the
distance from the secretion site. Because of the high time resolu-
tion of this method, not only can single exocytotic events be
recorded as current spikes, but kinetic parameters can be deter-
mined as well. ClC-3 KO cells that were stimulated to exocytose
by increasing [K]o to 50 mM displayed a significantly reduced
spike number per cell, current amplitude, and charge per spike
and total charge (i.e., charge per spike multiplied by spike num-
ber) per cell compared with WT cells (Fig. 4A,B, Table 1). In
addition, there were significantly less spikes displaying a foot
signal, which arises from a slow leakage of catecholamines
Figure 2. Strong expression of ClC-3 in numerous secretory tissues. A, B, ClC-3 is expressed
throughout the posterior pituitary (A) but is found in only a subset of cells of the anterior
pituitary (B). C, D, Also, within the thyroid, only a subset of cells (magnified in D) show promi-
nent vesicular ClC-3 staining. E, F, In the adrenal gland, the medullary chromaffin cells exhibit
strong staining (E),whereas there is onlyweak stainingof the adrenal cortexwith the exception
of the zonaglomerulosa (F ).G,H, In thepancreas, the endocrine islets of Langerhans (G) aswell
as the exocrine tissue (H ) stain for ClC-3, with particularly intense staining in islets. Scale bars:
A, B, F, 25m; C, G, 50m; D, 10m; E, 100m; H, 7.5m.
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through the fusion pore before full dila-
tion of the pore and complete exocytosis
(Chow et al., 1992). The probability of de-
tecting a foot signal is positively correlated
with the quantal size of a vesicle (Amatore
et al., 2005). The properties of the spike
foot in regards to its height, duration and
area were significantly reduced in KO cells
(Table 1). However, there was no change
in the kinetic parameters of the full am-
perometric spike such as rise time, decay
time, or half-width (Table 1).
We next determined whether the dif-
ferent exocytotic responses of WT and
ClC-3 KO chromaffin cells might be
caused by different levels of [Ca2]i elic-
ited by high-[K]o-stimulated depolariza-
tion. [Ca2]i of chromaffin cells wasmon-
itored by measuring the fluorescence of
fura-2 while depolarizing them with 50 or
100 mM [K]o. The relative basal [Ca
2]i
was not changed in ClC-3 KO cells, and
after stimulation with high K solution,
[Ca2]i rose to an equal extent in WT and
KO cells (Fig. 4C–E). Hence, the impaired
secretory response of ClC-3 KO cells can-
not be attributed to abnormalities of Ca2
handling, butmust be caused by a defect in
a later step in the series of events leading to
granule release.
Hormone concentrations in mice
The reduced release of catecholamines
from ClC-3 KO chromaffin cells, as indi-
cated by amperometry, might be corre-
lated with a changed catecholamine con-
tent of adrenal glands. However, direct
measurements of catecholamine contents
of WT and ClC-3 KO adrenal glands re-
vealed no significant difference (Table 2).
Because ClC-3 is prominently expressed
in pancreatic  cells (Fig. 2G, supple-
mental Fig. S2Ba, available at www.
jneurosci.org as supplemental material)
and because ClC-3 has been suggested to
be important for insulin secretion (Barg
et al., 2001), we also determined the in-
sulin contents of isolated islets (Table 2).
Again, no difference between the geno-
types was noted.
Because impaired secretion could lead to an altered steady-
state concentration of the affected hormones, we measured them
using ELISAs. Epinephrine and norepinephrine concentrations
in serum and urine samples of ClC-3 KO and WT mice showed
no significant differences either (Table 2). In contrast, serum
insulin levels were significantly lower in KO animals (Table 2).
However, ClC-3 KO mice weigh less than littermate controls
(Stobrawa et al., 2001), and insulin is regulated in a complex
manner to suit metabolic demands. Another key hormone in-
volved in metabolism is leptin. It negatively impinges on insulin
secretion by  cells (Seufert, 2004; Morioka et al., 2007). Leptin
concentrations were significantly increased in KO animals (Table
2). The observed decrease in serum insulin might therefore be
caused by changed leptin levels thatmay reflect the compromised
health state of ClC-3 KO mice.
Subcellular localization of ClC-3 in neuroendocrine cells
In view of the secretory defects of ClC-3 KO chromaffin cells
and the strong expression of ClC-3 in neuroendocrine cells, we
asked whether ClC-3 is not only expressed on endosomes and
synaptic vesicles (Stobrawa et al., 2001), but also on secretory
LDCVs. In chromaffin cells, this vesicle class stores and se-
cretes the catecholamines epinephrine and norepinephrine. In
pancreatic  cells, LDCVs store and secrete insulin. Both types
of neuroendocrine cells also contain SLMVs, which store ace-
tylcholine in chromaffin cells and GABA in pancreatic  cells.
LDCVs and SLMVs follow different biosynthetic pathways
with LDCVs originating from the trans-Golgi network (TGN)
Figure 3. Reduced exocytosis in ClC-3 KO chromaffin cells as revealed by capacitancemeasurements.A,B, Isolated chromaffin
cellswere subjected to a series of depolarizing pulses to 0mV fromaholdingpotential of70mV (500mspulse duration at 1Hz),
and themembrane capacitancewasmeasured after each pulse.A, Sample traces of capacitance changes in stimulatedWT and KO
cells.B, Mean capacitance changes induced by individual voltage pulses. The observed reduction in exocytosis of KO cells is highly
significant ( p  0.005). C, D, Secretion was triggered by the photolytic release of caged Ca 2. C, Averaged raw traces of
stimulatedWT and KO cells.D, Mean capacitance changes induced by caged Ca 2 release. ClC-3 KO cells displayed a significantly
reduced secretory response ( p 0.05). The arrows in C and D point to the onset of Ca 2 release. Data represent average
values SEM.
Figure 4. Reduced LDCV exocytosis in ClC-3 KO chromaffin cells measured by amperometry. Amperometric measurements
were performed as a read-out of catecholamine exocytosis. Isolated cells were stimulated by application of 50mM K containing
Krebs solution. A, B, Sample recordings of a WT and KO cell. Current spikes occurring within 60 s of stimulation were analyzed to
illustrate spike number per cell. Spike numbers, amplitudes, and other spike parameters were significantly different betweenWT
andKOcells (Table 1).C–E, Assessmentof thedepolarization-inducedCa 2 responseofWTandKOchromaffin cells.CandD show
averageCa 2-imagingexperiments performedwithWTandKOcells, respectively. Thebar under the curves indicates superfusion
with high [K]. E, Averaged relative change in intracellular Ca 2 concentration in response to high [K]o. There was no
significant difference in the Ca 2 response of WT and KO cells (n	 20). Error bars indicate SEM.
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and SLMVs from endosomal membranes (Thomas-Reetz and
De Camilli, 1994).
Isolated chromaffin cells were infected with Semliki Forest
virus-encodingHA-taggedClC-3 and costainedwith an antibody
against secretogranin II, a marker of LDCVs. Confocal micros-
copy revealed a lack of significant colocalization of ClC-3 with
secretogranin II (Fig. 5A). These results were confirmed by sub-
cellular fractionation. To obtain sufficient material, we used bo-
vine adrenal gland medulla that was fractionated by density gra-
dient centrifugation on a sucrose gradient (Fig. 5B). The fractions
were analyzed byWestern blotting using carboxypeptidase E and
secretogranin I and II as markers for LDCVs, and synaptophysin
as a marker for SLMVs. In chromaffin cells, synaptophysin is not
limited to SLMVs (like in cells) (see below), but is also found on
LDCVs (Fournier et al., 1989). In the resulting biphasic distribu-
tion of synaptophysin across the gradient, the synaptophysin
peak in fractions 7–11 represents SLMVs. The second peak in the
more dense fractions 16–19 corresponds to LDCVs, as revealed
by the presence of other LDCV markers. The prominent
-hexosaminidase activity within these LDCV-containing frac-
tions indicates lysosomal contamination. The ClC-3 signal copu-
rifies clearly with the first synaptophysin peak, whereas there is
hardly any signal in the denser fractions. Hence, ClC-3 expres-
sion could be found in a chromaffin cell fraction containing
SLMVs (and endosomes) (data not shown), butwas not foundon
LDCVs.
The prominent expression of ClC-3 in pancreatic  cells
(supplemental Fig. S2Ba, available at www.jneurosci.org as
supplemental material) and its proposed role in insulin exo-
cytosis (Barg et al., 2001) motivated us to additionally inves-
tigate the subcellular localization of ClC-3 in  cells. Previous
work using a different ClC-3 antibody in immunocytochem-
istry (that lacked KO controls) suggested the presence of
ClC-3 on insulin-containing LDCVs (Barg et al., 2001). Be-
cause antibodies against either insulin or ClC-3 stain almost
the entire cross-section of  cells (supplemental Fig. S2Ba,
available at www.jneurosci.org as supplemental material), im-
munofluorescence might erroneously suggest a colocalization
of both proteins. At high magnification, costaining  cells for
glucagon and ClC-3 (Fig. 6Ea–Ec), or  cells for insulin and
ClC-3 (Fig. 6Ed–Ef ), showed a broad overlap of diffuse stain-
ing. Importantly, many ClC-3-positive
puncta failed to show equivalent stain-
ing for glucagon or insulin, and vice
versa (Fig. 6Ec,Ef,Ei). The  cell lines
Rinm5F and INS-1E have less insulin-
containing LDCVs per cell and are there-
fore better suited for colocalization
studies. Unfortunately, staining cul-
tured cells with our ClC-3 antibody re-
sulted in a poor signal-to-noise ratio.
We therefore transfected myc-tagged
ClC-3 into INS-1E cells and costained
with insulin. No significant colocaliza-
tion was detected (Fig. 6F).
Although immunocytochemistry showed that insulin and
ClC-3 are not strictly colocalized in  cells, these experiments
could neither exclude nor confirm a partial coresidence in the
same vesicles.We therefore turned to subcellular fractionation of
 cell lines to separate LDCVs from SLMVs and endosomes.
Western blot analysis (supplemental Fig. S3Aa, available at ww-
w.jneurosci.org as supplemental material) indicated that both
INS-1E and Rinm5F  cell lines expressed, to different extents,
the vesicular Cl transporters ClC-3, ClC-4, ClC-5, ClC-6 and
ClC-7, as well as carboxypeptidase E and synaptophysin (marker
proteins for LDCVs and SLMVs, respectively). Homogenates of
INS-1E cells were centrifuged on continuous sucrose gradients.
The resulting fractionswere probed inWestern blots for vesicular
CLCs and marker proteins (Fig. 6), and analyzed for protein and
insulin contents and the activity of the lysosomal enzyme
-hexosaminidase (Fig. 6B–D). LDCVs were detected by their
insulin contents and the presence of the LDCV marker car-
boxypeptidase E in fractions 9–14, with a peak at fraction 10–11.
These LDCV fractions were heavily contaminated by lysosomes,
as indicated by the presence of -hexosaminidase and cathepsin
D (Fig. 6A,D). Probing for synaptophysin showed that fractions
4–9 (peak: 6–7) contained SLMVs. Endosomal markers [rab4
and transferrin receptor (TfR)] peaked in the same fractions.
Thus, SLMVs and endosomes (fractions 4–9) were separated
from LDCVs (fractions 9–14). ClC-3 was detected by two differ-
ent, KO-controlled antibodies (3A4 and 3E3) directed against the
N and C termini of ClC-3, respectively (Stobrawa et al., 2001).
Both antibodies detected ClC-3 in fractions 5–8, which contain
endosomes and SLMVs. Almost no ClC-3 was detected in frac-
tions 10–12 that contain the bulk of LDCVs. These results agree
with the published localization of ClC-3 to endosomes and syn-
aptic vesicles (Stobrawa et al., 2001; Salazar et al., 2004; Hara-
Chikuma et al., 2005b), but do not support the presence of ClC-3
on insulin granules as suggested by others (Barg et al., 2001).
ClC-7 was the only vesicular CLC that could be detected in sig-
nificant amounts in fractions containing LDCVs. However, this
can be explained by ClC-7 being in lysosomes (Kornak et al.,
2001; Kasper et al., 2005), which contaminated these fractions.
Consistent with their known localization on endosomes
(Gu¨nther et al., 1998; Piwon et al., 2000; Poe¨t et al., 2006), ClC-5
Table 1. Effects of ClC-3 on chromaffin cells amperometric spike parameters
Spike no.
per cell
Amplitude
(pA) Charge (pC)
Total charge
per cell (pC)
Rise time
(ms)
Decay time
(ms)
Half-width
(ms)
Foot fre-
quency (%)
Foot area
(fC)
Foot duration
(ms)
Foot height
(pA)
WT (n	 15) 74 11 37.7 4.2 303 37 34.7 7.5 0.79 0.1 4.8 0.5 4.8 0.5 38.9 4.6 46 3.1 5.1 0.3 22.1 0.9
KO (n	 15) 49 8* 23.8 2.8** 162 27** 11.2 2.9** 0.73 0.14 4.4 0.7 4.4 0.7 24.1 4.4* 30 2.9** 3.9 0.3** 18.5 1.3*
Data are shown as mean SEM of the cell median for each parameter. Numbers in parentheses in the left column are number of cells used to calculate the number of exocytotic events.
*p 0.05, **p 0.01, differences betweenWT and KO.
Table 2. Hormones inWT and ClC-3 KO tissues and serum samples
WT SEM n KO SEM n p
Catecholaminesg/mg adrenal gland 4.83 0.43 24 4.93 0.36 21 
0.05
Insulin ng/islet 47.54 8.33 4 40.48 5.98 4 
0.05
Epinephrine pg/ml serum 145.0 20.5 5 186.4 18.7 5 
0.05
Epinephrine ng/ml urine 19.28 3.55 15 34.98 90.94 15 
0.05
Norepinephrine pg/ml serum 1290 273 5 1528 336 5 
0.05
Norepinephrine pg/ml urine 91.76 9.72 15 113.17 11.72 15 
0.05
Insulin ng/ml serum 1.46 0.17 20 0.99 0.10 19 0.05
Leptin ng/ml serum 1.81 0.22 20 2.88 0.38 19 0.05
Therewasno significant differencebetween thegenotypes in the insulin content of islets or the catecholamine content of adrenal glands, and serumandurine
concentrations of catecholamines. However, insulin levels were decreased in KO mice, whereas serum leptin levels were increased.
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and ClC-6 copurified with endosomal
markers (Fig. 6A). These fractions also
contained ClC-7 (Kornak et al., 2001;
Kasper et al., 2005).
We reproduced these findings in an-
other insulin-secreting cell line (Rinm5F)
(supplemental Fig. S3Ab,Ac, available at
www.jneurosci.org as supplemental mate-
rial) and with the limited amount of mate-
rial that is available frommouse pancreatic
islets (supplemental Fig. S3B, available at
www.jneurosci.org as supplemental mate-
rial). ClC-3 was again detected in fractions
containing endosomes and SLMVs, but
was virtually undetectable in fractions en-
riched for insulin and carboxypeptidase E.
The above experiments detected ClC-3
in fractions containing both endosomes
and SLMVs. Nonequilibrium centrifuga-
tion of INS-1E homogenates on a glycerol
gradient was used to separate these two
similarly dense vesicle populations (Fig.
6F). BothClC-3 andClC-5were present in
fractions enriched for the endosomal
marker TfR, whereas ClC-3, but not
ClC-5, was detected in fractions 4–6 that
contain SLMVs while being devoid of en-
dosomes, as indicated by the presence of
synaptophysin and the absence of TfR, re-
spectively. We conclude that ClC-3 is
present on both endosomes and synaptic-
like microvesicles in both types of neu-
roendocrine cells, but is not detectable on
LDCVs.
Discussion
The subcellular localization and physio-
logical function of ClC-3 has been contro-
versial. Several authors, including our-
selves, found ClC-3 on endosomes and
synaptic vesicles (Stobrawa et al., 2001; Li
et al., 2002; Salazar et al., 2004; Hara-
Chikuma et al., 2005b; Suzuki et al., 2006;
Weylandt et al., 2007; Zhao et al., 2007),
but others described ClC-3 as a plasma
membrane channel (Kawasaki et al., 1994;
Duan et al., 1997; Huang et al., 2001;
Isnard-Bagnis et al., 2003; Wang et al.,
2006). ClC-3 was also reported to localize
to insulin-containing LDCVs of pancre-
atic  cells (Barg et al., 2001). Many of those studies were per-
formed with transfected cells or lacked KO controls.
Using KO controlled immunocytochemistry, we show that
ClC-3 is predominantly (if not exclusively) a vesicular protein in
all tissues examined. ClC-3 expression is particularly high in neu-
roendocrine cells, where it is found on endosomes and SLMVs.
Although ClC-3 was not detectable on LDCVs, the exocytosis of
these vesicles was decreased in chromaffin cells.
In epithelial cells of the proximal tubule and the epididymis,
ClC-3 expression appeared confined to vesicles of the apical cell
pole. This resembles the presence of ClC-5 on apical endosomes
of renal proximal tubular (Gu¨nther et al., 1998; Sakamoto et al.,
1999; Piwon et al., 2000) and intestinal epithelial cells (Vande-
walle et al., 2001), and in apical vesicles of acid-secreting cells of
the distal renal tubule (Gu¨nther et al., 1998; Sakamoto et al.,
1999) and epididymis (Isnard-Bagnis et al., 2003). Our KO-
controlled staining does not support the reported plasma mem-
brane localization of ClC-3 in epididymal epithelia (Isnard-
Bagnis et al., 2003).
Neuronal cell bodies showed punctate, intracellular ClC-3
staining, consistent with an endosomal localization as in other
cells. Neuropil was labeled intensely, with ClC-3 immunoreactiv-
ity partially overlapping with synaptophysin, in accord with
ClC-3 being on SVs (Stobrawa et al., 2001; Salazar et al., 2004).
Subcellular fractionation of neurosecretory cells showed that
ClC-3 is not only on endosomes and SVs, but also on SLMVs,
Figure5. Subcellular localization of ClC-3 in chromaffin cells.A, Immunocytochemistry of isolated chromaffin cells obtained at
embryonic day 17 that were transfected with HA-tagged ClC-3 and costained for the HA-tag and the LDCV marker secretogranin
II. There is hardly any overlap betweenClC-3 and LDCVs. Scale bar, 2.5m.B, Subcellular fractionation of vesicle preparation from
bovine adrenalmedulla on a sucrose step gradient that was centrifuged for 16 h at 100,000 g. Twenty fractions were collected
from top to bottom, TCA precipitated, and analyzed by Western blotting. Synaptophysin-specific antibodies were used to detect
SLMVs and LDCVs. LDCVs were additionally detected by antibodies against secretogranin I and II and against carboxypeptidase E
(CPE).-Hexosaminidase enzymatic activity was assayed as marker for lysosomes. ClC-3 was detected using the antibody 3A4.
ClC-3 peaks in the less dense fractions 7–9 that contain the first peak of synaptophysin signal,whereas the different LDCVmarkers
show highest intensity in the denser fractions 15–20.
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Figure 6. Presence of ClC-3 on SLMVs and endosomes of insulin-secreting INS-1E cells. A–D, Subcellular fractionation of INS-1E homogenates. Seventeen fractions (starting from the top) were
collected after sucrose gradient centrifugation.A, Theywere analyzed byWestern blottingwith antibodies directed against cathepsin D (lysosomalmarker), carboxypeptidase E (CPE; LDCVmarker),
rab4 and transferrin receptor (endosomalmarkers), synaptophysin (SLMVmarker), and ClC-3, ClC-5, ClC-6, ClC-7.B, C, Protein content (B) and insulin concentration (as additionalmarker for LDCVs;
C) of individual fractions.D,-Hexosaminidase activitywasmeasured asmarker for lysosomes. LDCVs and lysosomes peak in a heavier fractions (9–13) than endosomes and SLMVs (fractions 5–9).
ClC-3,ClC-5,andClC-6werepresent infactionscontainingendosomesandSLMVs.Onlythe lysosomalClC-7wasfoundalso inheavier fractions.Fractions1–4correspondtothe“load”of thegradientandcontain
solubleproteins, includingproteins leakedoutofdisruptedvesicles.E, Immunocytochemistry reveals thatClC-3doesnotcolocalizesignificantlywithglucagon-or insulin-containingLDCVs.Ea–Ec, Pancreatic
cell costainedforClC-3andglucagon.Ed–Ef,Pancreaticcell costainedforClC-3andinsulin,bothinnative islet.Eg–Ei,CulturedINS-1Ecellsoverexpressingmyc-taggedClC-3showthatClC-3andinsulinclearly
do not colocalize in these cells. Scale bars: Ea–Ef, 5m; Eg–Ei, 10m. Ec, Ef, Ei, Insets, Highermagnification of boxed areas. F, To separate endosomes and SLMVs, INS-1E supernatants were subjected to
velocity centrifugation on a 5–25% glycerol gradient with a 50% sucrose cushion. Fraction 1 corresponds to the top of the gradient. Equal volumes of each fraction were analyzed byWestern blotting with
antibodies against transferrin receptor, ClC-5 (endosomal markers), synaptophysin (SLMVmarker in addition to its presence on recycling endosomes), and ClC-3. In contrast to transferrin receptor
and ClC-5, ClC-3 is not only present on endosomes, but also on distinct synaptophysin-positive membranes, which most likely represent SLMVs.
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which share many properties with neuronal SVs (Thomas-Reetz
and De Camilli, 1994). Our results agree with the localization of
ClC-3 to SLMVs of PC12 cells (Salazar et al., 2004). The promi-
nent staining for ClC-3 in neurosecretory cells may be owed to
the distribution of SLMVs over their entire cell body, whereas
neuronal synaptic vesicles are confined to tiny presynaptic
boutons.
Apart from SLMVs, secretory cells contain LDCVs that store
hormones like insulin or catecholamines and originate from the
TGN (Thomas-Reetz and De Camilli, 1994). ClC-3 could not be
detected on LDCVs in either chromaffin cells or pancreatic 
cells. For  cells, our findings contrast previous work reporting
prominent ClC-3 expression on insulin granules (Barg et al.,
2001). However, the antibody used in that study also stained KO
tissue in our hands. Furthermore, the dense staining of  cells for
both ClC-3 and insulin precludes comparative staining of single
vesicles and the dense package of LDCVs between a large number
of much smaller SLMVs renders the interpretation of immuno-
gold labeling difficult. The reported inhibition of -cell exocyto-
sis by SITS (Barg et al., 2001) is also difficult to interpret. Al-
though no data are available on ClC-3, the related compound
DIDS poorly inhibited the highly related Cl/H exchanger
ClC-5 when applied from either the outside (Steinmeyer et al.,
1995) or inside (our unpublished results). Furthermore, these
nonspecific inhibitors do not even target only anion transporters
(Vega et al., 1988; Jentsch et al., 1989).
In apparent contrast to a role of ClC-3 in insulin exocytosis,
Dickerson et al. (2002) did not find abnormalities in glucose
tolerance tests in their Clcn3/mice that would have hinted at
an insulin secretion defect. However, in vivo studies of insulin
secretion in Clcn3/ mice should be interpreted with caution.
These mice not only have severe neurodegeneration, but are sys-
temically sick and display marked growth retardation and
changed hormonal status (Stobrawa et al., 2001; Dickerson et al.,
2002). In addition to decreased insulin levels, KO mice had in-
creased serum leptin concentrations. Leptin negatively regulates
insulin secretion by variousmechanisms (Seufert, 2004;Morioka
et al., 2007), potentially explaining the decreased resting insulin
concentrations in our Clcn3/ mice. This hypothesis is sup-
ported by our observation that both leptin and insulin concen-
trations were similar to controls in-cell-specific ClC-3 KOmice
(our unpublished data).
We chose chromaffin cells as a well-establishedmodel for reg-
ulated exocytosis (Borges et al., 2008) to examine consequences
of Clcn3 disruption on exocytosis. Like pancreatic  cells, chro-
maffin cells contain two secretory vesicle populations, i.e., LD-
CVs andmuch smaller SLMVs. To our surprise, both capacitance
and amperometry experiments indicated that loss of ClC-3 sig-
nificantly impaired chromaffin cell exocytosis. It is unlikely that
this impairment reflects decreased exocytosis of SLMVs, which,
in contrast to LDCVs, express detectable levels of ClC-3. SLMV
exocytosis would only moderately increase membrane capaci-
tance because of their small size. Indeed, amperometry directly
showed a decreased secretion of catecholamines, the hormone
stored in LDCVs (SLMVs contain acetylcholine in chromaffin
cells). The reduced capacitance increase observed even at the first
pulse indicates a reduction in docked vesicles that are ready to
fuse, i.e., smaller readily releasable pool. The decreased frequency
of spikes observed in amperometry points to a reduced fusion
frequency, whereas the reduction in peak size suggests a reduced
catecholamine content of individual LDCVs (Pothos et al., 2002).
On the systemic level, the impaired secretory capacity of ClC-3
KO chromaffin cells we observed after strong stimulation in vitro
did not compromise the ability of the KO animals to maintain
normal catecholamine levels in vivo.
There are several alternative explanations for the effect of
ClC-3 on LDCV exocytosis. One could speculate that minor
amounts of ClC-3, which are below our detection limit, are ex-
pressed on LDCVs. Similar to its proposed role in endosomes and
SVs, ClC-3 could contribute to their luminal acidification by
providing a shunt conductance for the proton pump. Luminal
acidification is not only important for the loading of vesicles,
which may be affected in Clcn3/mice as suggested by amper-
ometry, but also for exocytosis itself (Taupenot et al., 2005; Ca-
macho et al., 2006). However, in pituitary AtT20 secretory cells,
no effect of chloride on secretory granule acidification was found
(Wu et al., 2001).
In view of our inability to detect ClC-3 on LDCVs of chromaf-
fin and  cells, although it is so strongly expressed on their endo-
somes and SLMVs, and considering the differences in biogenesis
of SLMVs and LDCVs (Thomas-Reetz and De Camilli, 1994), we
rather prefer the hypothesis that the lack of ClC-3 primarily af-
fects other trafficking and sorting events in these cells. By analogy
to ClC-5, a very close relative of ClC-3, the loss of ClC-3 in en-
dosomes may underlie the effects observed here. ClC-5 ablation
results in defective endosomal acidification (Gu¨nther et al., 2003;
Hara-Chikuma et al., 2005a) accompanied by a severe reduction
in endocytosis (Piwon et al., 2000; Wang et al., 2000) and im-
pairedmembrane protein recycling. For instance, the abundance
and plasma membrane localization of the endocytotic receptor
megalin is decreased in proximal tubules lacking ClC-5 (Piwon et
al., 2000; Christensen et al., 2003). A similar endosomal acidifi-
cation defect might perturb endocytosis and recycling in
Clcn3/ chromaffin cells. Endocytosis and exocytosis are tightly
interwoven. LDCV membrane proteins are recycled after exocy-
tosis rather than being synthesized anew every time, and this
recycling probably involves an endosomal intermediate (Vo et
al., 2004). Both SLMVs and LDCVs are retrieved as vesicles with
a diameter of 70 nm in Ins1 cells (MacDonald et al., 2005), and
rapid endocytosis follows exocytosis in chromaffin cells (Perez
Bay et al., 2007). Thus, as endocytosis ensures the necessary abun-
dance and localization of membrane proteins, defects in endocy-
tosis and recycling entail exocytosis defects. A defect in the endo-
cytotic fission protein dynamin, for instance, has been reported
to impair exocytosis of synaptic vesicles (Kawasaki et al., 2000). If
an important protein of the exocytotic fusion machinery had
reduced plasma membrane localization because of defective re-
cycling, it might become rate limiting and reduce exocytosis al-
ready at the first pulse. Future studies will need to address the
impact of ClC-3 on chromaffin cell endocytosis.
The lack of ClC-3 affects the acidification of both synaptic
vesicles (Stobrawa et al., 2001) and endosomes (Hara-Chikuma
et al., 2005b), similar to the impaired acidification of renal corti-
cal endosomes observed after ClC-5 disruption (Gu¨nther et al.,
2003). Although ClC-3 is expressed in apical vesicles of proximal
tubules, no proteinuria was observed in ClC-3 KO mouse, quite
in contrast tomice lacking endosomal ClC-5 (Piwon et al., 2000).
In the proximal tubule, however, the lack of ClC-3 might be
compensated for by the prominent expression of ClC-5. In this
respect, it is interesting to note that we found significant levels of
ClC-5 in endosomal fractions of cells, and of ClC-4 in chromaf-
fin cells. Thus, one may speculate that deleting ClC-3 together
with ClC-4 or ClC-5 might lead to a more severe secretory phe-
notype if it depends on endosomal trafficking. Given the severe
phenotypes of such doubleKOs (our unpublished observation), a
test of this hypothesis will require tissue- or cell-specific KOs.
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